About Brentuximab Vedotin
Class: | Antineoplastic agent, CD30-directed antibody-drug conjugate
Use: | Treatment of adult patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant, and for patients with systemic anaplastic large cell lymphoma (sALCL)
Adult dose: | 1.8 mg/kg administered as an intravenous infusion every 3 weeks; maximum dose is 180 mg
Pediatric dose: | Safety and efficacy not established in pediatric patients; dosing is not recommended
Side effects: | Peripheral ne
Drug Class
Antineoplastic agent, CD30-directed antibody-drug conjugate
Uses & Indications
Treatment of adult patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant, and for patients with systemic anaplastic large cell lymphoma (sALCL)
Storage Requirements
Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: Takeda Pharma A/S, DENMARK
Package Size
1 Glass Vial
Price & Supplier
Price in UAE: AED 19181.50
Dosage Information
Adult Dose
1.8 mg/kg administered as an intravenous infusion every 3 weeks; maximum dose is 180 mg
Pediatric Dose
Safety and efficacy not established in pediatric patients; dosing is not recommended
Side Effects
Peripheral neuropathy, neutropenia, nausea, fatigue, diarrhea, fever, rash
Contraindications & Precautions
Hypersensitivity to Brentuximab Vedotin or any component of the formulation; caution in patients with a history of progressive multifocal leukoencephalopathy (PML)
Important Warnings
Risk of serious infections, including PML; monitor for signs of infusion reactions; may cause fetal harm; avoid use in pregnancy unless necessary
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.